Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-28

Clinical Trial Update: Role of Prohepcidin in Uremic Patients

View source ↗

Summary

Completed clinical trial evaluating prohepcidin in uremic patients; conditions include inflammation and chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Haseki Training and Research Hospital | Conditions: Inflammation, Chronic Kidney Disease | Status: COMPLETED